The Akkermansia Company has patents protecting the use of the Akkermansia species, including the use of the MucT strain’s pasteurized version, which is its most bio-efficacious form.
The proposed $36 billion acquisition has received all but one of 28 required regulatory clearances. Antitrust review by the European Commission is ongoing.
The transaction expands C.H. Guenther’s tortilla manufacturing capacity and deepens its relationships with foodservice and quick-service restaurant customers.
CMI supported over 350 construction-related jobs during the development of the plant and expects to add an additional 150 jobs once the facility opens in the fall.